Major Program
Supportive Care and Symptom Management
NCI Community Oncology Research Program
Research Group
Community Oncology and Prevention Trials
Sponsor
Wake Forest University Health Sciences
Status
Active, not recruiting
ClinicalTrials.gov ID
For more information, see ClinicalTrials.gov NCT03935282
The objective of this hybrid effectiveness-implementation study is to examine the effects of
an EHR-based cardiovascular health assessment tool (AH-HA) among breast, prostate,
colorectal, endometrial, and Hodgkin and non-Hodgkin lymphoma cancer survivors (N=600)
receiving survivorship care in community oncology practices, using a group-randomized trial
design (6 intervention practices and 6 usual care practices). Our central hypothesis is that
the AH-HA tool will increase (1) cardiovascular health (CVH) discussions among survivors and
oncology providers, (2) referrals and visits to primary care and cardiology (care
coordination), and (3) cardiovascular (CV) risk reduction and health promotion activities
compared to usual care.
an EHR-based cardiovascular health assessment tool (AH-HA) among breast, prostate,
colorectal, endometrial, and Hodgkin and non-Hodgkin lymphoma cancer survivors (N=600)
receiving survivorship care in community oncology practices, using a group-randomized trial
design (6 intervention practices and 6 usual care practices). Our central hypothesis is that
the AH-HA tool will increase (1) cardiovascular health (CVH) discussions among survivors and
oncology providers, (2) referrals and visits to primary care and cardiology (care
coordination), and (3) cardiovascular (CV) risk reduction and health promotion activities
compared to usual care.
Intervention
AH-HA Tool in the EPIC EHR
Condition
Breast Neoplasm, Prostatic Neoplasm, Colorectal Neoplasms, Endometrial Neoplasms, Hodgkin Disease, Non Hodgkin Lymphoma
Investigators
Kathryn Weaver, MD